<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">348132</id>
  <title nil="true"/>
  <common-name>4-[(5z)-5-[[3-(4-butoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid</common-name>
  <description>4-[(5z)-5-[[3-(4-butoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid is a chemical compound with the formula C28H29N3O4S2. With an average molecular weight of 535.70 g/mol, 4-[(5z)-5-[[3-(4-butoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid is a heavy molecule.</description>
  <cas>623940-49-8</cas>
  <pubchem-id>6249029</pubchem-id>
  <chemical-formula>C28H29N3O4S2</chemical-formula>
  <weight>535.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T12:02:24Z</created-at>
  <updated-at type="dateTime">2026-08-31T12:02:24Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCCOC1=C(C=C(C=C1)C2=NN(C=C2C=C3C(=O)N(C(=S)S3)CCCC(=O)O)C4=CC=CC=C4)C</moldb-smiles>
  <moldb-formula>C28H29N3O4S2</moldb-formula>
  <moldb-inchi>InChI=1S/C28H29N3O4S2/c1-3-4-15-35-23-13-12-20(16-19(23)2)26-21(18-31(29-26)22-9-6-5-7-10-22)17-24-27(34)30(28(36)37-24)14-8-11-25(32)33/h5-7,9-10,12-13,16-18H,3-4,8,11,14-15H2,1-2H3,(H,32,33)/b24-17-</moldb-inchi>
  <moldb-inchikey>IVERBBCDQHIQMV-ULJHMMPZSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">535.1599488</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM344025</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4-[(5z)-5-[[3-(4-butoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Pyrazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298467</sync-id>
  <structure-inchikey>IVERBBCDQHIQMV-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>400000000000000008002400000000000000000000000000001000000000000004040020000201000000000000020040000000000000000008000000000000000000000000000000900000000000000200000100003000002000000000000000000200100000800000001001100008000080001001080400000000000000000000041c0000000800002000000004000800000000100000000000000000000010000000000000000000000080100000000000020090002020200040002000000000008000000000000000000000000000000000000042800400200000000000000000040000000000040000000810400000000080030000000000a0000000c</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:36Z</structure-indexed-at>
</compound>
